Institute of Genetics and Cancer

Latest News

The following news articles were published in 2024.

Adjuvant pembrolizumab improves survival in high-risk clear cell renal cell cancer

Pembrolizumab (Keytruda) prevents PD‑L1 and PD‑L2 ligand proteins on tumour cells from binding with PD⁠-⁠1 receptors on T cells
Recent results from the KEYNOTE-564 trial, an international study with its UK component led from Edinburgh, support adjuvant pembrolizumab as a standard of care after surgery for patients with clear cell renal cell cancer (kidney cancer): April 2024

Innovation and Entrepreneurship Award for University of Edinburgh and Nuvectis

Innovation and Entrepreneurship Awards 2024
University of Edinburgh and Nuvectis Pharma win Innovation and Entrepreneurship Award

Generation Scotland halfway to recruiting 20k new volunteers

Generation Scotland logo
Generation Scotland, Scotland’s largest family health study, hit an incredible 10,000 new volunteer sign-ups at the end of February, marking the halfway point to their total recruitment target of 20,000.

Research groups join forces to study the genetics of Parkinson’s disease

The Grzegorz Kudla Research Group at the MRC Human Genetics Unit, University of Edinburgh will join forces with colleagues at the MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee: March 2024

People living with Hypermobile Ehlers-Danlos Syndrome share their experiences

Kathryn Berg and Dervil Dockrell hosted the HSD/hEDS: Translating Research into Change event at the Institute on 8 February to hear from people living with the conditions and to share research developments.

Report makes recommendations to remove interdisciplinary research barriers

The X-Net project – a partnership between the Universities of Edinburgh, Dundee, and Oxford – publishes its recommendations following extensive consultation with the biomedical research community.

Versus Arthritis Fellow Dr Erika Kague joins IGC

Headshot of Erika Kague
Dr Kague will develop a research programme investigating the role of osteocytes in bone diseases

Institute hosts Scotland Rare Disease Day Reception

Rare Disease UK, a Genetic Alliance UK campaign to raise awareness of rare diseases, marked International Rare Disease Day 2024 at the Institute on Tuesday 27 February.

Growing recognition for QuPath software led from the IGC

Cartoon of scientists in front of QuPath logo
QuPath’s importance for research highlighted by workshops, talks, announcements, downloads, and an awards ceremony at the House of Lords.

Welcoming Dr Nezha Benabdallah to the Institute of Genetics and Cancer

Nezha Benabdallah
Dr Nezha Benabdallah, geneticist and cancer researcher, joins the Institute of Genetics and Cancer as a new principal investigator: February 2024

Carragher Lab honours Emily’s memory

The family of a woman who died from a brain tumour aged just 31 have unveiled a plaque on the wall of the Neil Carragher Research Group lab, where the work they’ve helped to fund takes place: February 2024

Autophagy linked to enhanced oncogenic signalling and brain tumour development

Graphical abstract of the study by Simpson et al.
A study shows that autophagy regulates oncogenic signalling of platelet-derived growth factor receptor alpha (PDGFRA) and that the absence of autophagy disrupts PDGFRA-driven brain tumour development: January 2024

First comprehensive molecular picture of ovarian carcinosarcoma

Genomic features of ovarian carcinosarcoma (OCS)
A study led by our scientists provides the first comprehensive molecular picture of ovarian carcinosarcoma (OCS), an uncommon form of ovarian cancer: January 2024

LOCOME project awarded Innovate UK grant to improve diagnosis and treatment of ME/CFS and Long COVID

The MRC Human Genetics Unit are collaborating with PrecisionLife and Action for M.E. in an innovative precision medicine project providing hope to millions in the UK: December 2023

DNA methylation rates linked to maximum lifespan in mammals

Researchers from the MRC Human Genetics Unit show slower DNA methylation rates in longer lived mammals, such as whales, compared to shorter lived mammals, like rats: December 2023

Dervil Dockrell and Kathryn Berg named 2023 Ehlers-Danlos Support UK Community Champions

Kathryn Berg and Dervell Dockrell with their EDS UK Community Champion Award Certificates
The researchers were honoured at an award presentation at the Institute of Genetics and Cancer: November 2023